Fred J. Roisen
Corporate Officer/Principal bij University of Louisville
Profiel
Fred J.
Roisen is the founder of RhinoCyte, Inc. which was founded in 2005.
He held the title of President & Chief Executive Officer from 2009 to 2013.
Currently, he is a Professor at the University of Louisville since 1986.
Dr. Roisen has an undergraduate degree from Northeastern University and graduate and doctorate degrees from Princeton University.
Actieve functies van Fred J. Roisen
| Bedrijven | Functie | Begin |
|---|---|---|
| University of Louisville | Corporate Officer/Principal | 01-01-1986 |
Eerdere bekende functies van Fred J. Roisen
| Bedrijven | Functie | Einde |
|---|---|---|
RhinoCyte, Inc.
 RhinoCyte, Inc. Medical SpecialtiesHealth Technology RhinoCyte, Inc. develops and commercializes diagnostic tools and therapies. The firm engages in the discovery and development of products to extend and enhance the quality of human life. Its technology facilitates functional recovery in patients, including therapeutic stem cell transplantation with cells from the patient's own nasal cavity eliminating the need for immunosuppressive therapy. The company was founded by Fred J. Roisen and Steven R. Gailar in 2005 and is headquartered in Louisville, KY. | Oprichter | - |
Opleiding van Fred J. Roisen
| Princeton University | Doctorate Degree |
| Northeastern University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
RhinoCyte, Inc.
RhinoCyte, Inc. Medical SpecialtiesHealth Technology RhinoCyte, Inc. develops and commercializes diagnostic tools and therapies. The firm engages in the discovery and development of products to extend and enhance the quality of human life. Its technology facilitates functional recovery in patients, including therapeutic stem cell transplantation with cells from the patient's own nasal cavity eliminating the need for immunosuppressive therapy. The company was founded by Fred J. Roisen and Steven R. Gailar in 2005 and is headquartered in Louisville, KY. | Health Technology |
